Finance

Beta
Lists
UNICHEMLAB:NSE
Unichem Laboratories Ltd
₹379.80
+6.42%
(+22.90) 1D
Jun 9, 3:11:08 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for UNICHEMLAB...
Open
₹363.40
High
₹383.00
Low
₹359.60
Mkt. cap
26.74B
Avg. vol.
29.63K
Volume
45.16K
P/E ratio
10.59
52-wk high
₹666.60
52-wk low
₹278.20
EPS
₹35.85
Shares outstanding
70.38M
No. of employees
3K
Open
₹363.40
High
₹383.00
Low
₹359.60
Mkt. cap
26.74B
Avg. vol.
29.63K
Volume
45.16K
P/E ratio
10.59
52-wk high
₹666.60
52-wk low
₹278.20
EPS
₹35.85
Shares outstanding
70.38M
No. of employees
3K
News stories
From sources across the web
Profile
Unichem Laboratories is an Indian pharmaceutical company, headquartered in Mumbai. It manufactures and markets pharmaceutical formulations across the globe, including the regulated markets of the USA and Europe. Wikipedia
About Unichem Laboratories Ltd
CEO-
Employees3.14K
Founded1944
HeadquartersMumbai, Maharashtra, India
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
5.27B
5.79B
5.21B
5.75B
Cost of goods sold
2.45B
2.70B
2.37B
2.68B
Cost of revenue
2.45B
2.70B
2.37B
2.68B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.07B
1.00B
992.70M
928.50M
Operating expense
2.91B
2.74B
2.71B
2.90B
Total operating expenses
5.36B
5.44B
5.08B
5.58B
Operating income
-93.00M
347.10M
135.30M
170.70M
Other non operating income
53.40M
209.70M
118.00M
234.70M
EBT including unusual items
-90.20M
-108.20M
2.93B
187.90M
EBT excluding unusual items
-105.00M
474.40M
179.10M
311.50M
Income tax expense
14.50M
10.70M
291.40M
78.80M
Effective tax rate
-16.08%
-9.89%
9.93%
41.94%
Other operating expenses
1.52B
1.42B
1.40B
1.67B
Net income
-104.70M
-118.90M
2.64B
109.10M
Net profit margin
-1.99%
-2.05%
50.71%
1.90%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-65.40M
-82.40M
-74.20M
-93.90M
Net interest expenses
-65.40M
-82.40M
-74.20M
-93.90M
Depreciation and amortization charges
317.90M
314.70M
312.50M
306.10M
EBITDA
200.42M
663.40M
428.72M
464.12M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more